838 related articles for article (PubMed ID: 16729605)
21. Comparison of systematic mediastinal lymph node dissection versus systematic sampling for lung cancer staging and completeness of surgery.
Wu N; Yan S; Lv C; Feng Y; Wang Y; Zhang L; Yang Y
J Surg Res; 2011 Dec; 171(2):e169-73. PubMed ID: 21962744
[TBL] [Abstract][Full Text] [Related]
22. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
23. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of extended mediastinal lymph node dissection on the basis of clinicopathological analysis of nodal involvement in bronchogenic carcinoma].
Watanabe Y; Hayashi Y; Takabatake I; Shimizu J; Murakami S; Morita K; Arano Y; Nonomura A
Kyobu Geka; 1994 Jan; 47(1):4-9. PubMed ID: 8277631
[TBL] [Abstract][Full Text] [Related]
25. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
[TBL] [Abstract][Full Text] [Related]
26. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy.
Sakao Y; Miyamoto H; Yamazaki A; Ou S; Shiomi K; Sonobe S; Sakuraba M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):543-7. PubMed ID: 16870462
[TBL] [Abstract][Full Text] [Related]
27. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
28. Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations.
Yoshimasu T; Miyoshi S; Oura S; Hirai I; Kokawa Y; Okamura Y
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):433-7. PubMed ID: 16077409
[TBL] [Abstract][Full Text] [Related]
29. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
30. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.
Kotoulas CS; Foroulis CN; Kostikas K; Konstantinou M; Kalkandi P; Dimadi M; Bouros D; Lioulias A
Lung Cancer; 2004 May; 44(2):183-91. PubMed ID: 15084383
[TBL] [Abstract][Full Text] [Related]
31. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
[TBL] [Abstract][Full Text] [Related]
33. [Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].
Ota S; Inaba H; Yoshida H
Kyobu Geka; 2001 Dec; 54(13):1073-8; discussion 1078-81. PubMed ID: 11761888
[TBL] [Abstract][Full Text] [Related]
34. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Minnich DJ
Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
36. Re-evaluation of non-palpable scalene lymph node biopsy for the staging of non-small cell lung cancer.
Ohno K; Utsumi T; Sasaki Y; Suzuki Y
Eur J Cardiothorac Surg; 2004 Apr; 25(4):492-6. PubMed ID: 15037260
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
Casali C; Stefani A; Natali P; Rossi G; Morandi U
Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
[TBL] [Abstract][Full Text] [Related]
39. [Strategy for surgical treatment for small peripheral carcinoma of the lung especially on systemic nodal dissection].
Watanabe A; Osawa H; Obama T; Watanabe T; Mawatari T; Ichimiya Y; Takahashi N; Abe T; Sato M; Abe S; Kusajima K
Kyobu Geka; 2004 Jan; 57(1):20-4. PubMed ID: 14733094
[TBL] [Abstract][Full Text] [Related]
40. Operative results of non-small cell lung cancer clinically presenting mediastinal lymph adenopathy.
Yoshino I; Yamaguchi M; Yohena T; Kameyama T; Kometani T; Osoegawa A; Maehara Y
Fukuoka Igaku Zasshi; 2003 Aug; 94(8):250-8. PubMed ID: 14579727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]